It has been demonstrated that SCFAs have important roles in stimulating glucagon-like peptide-1 (GLP-1) and insulin secretion, ameliorating inflammation response, and improving glucose intolerance and insulin resistance (43–45). This evidence concerns the gene GCG and Insulin resistance.